Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $57,323 | 16 | 81.2% |
| Travel and Lodging | $7,661 | 35 | 10.9% |
| Honoraria | $3,500 | 1 | 5.0% |
| Food and Beverage | $1,974 | 42 | 2.8% |
| Education | $99.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $31,665 | 48 | $0 (2022) |
| ViiV Healthcare Company | $17,680 | 14 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $16,847 | 25 | $0 (2021) |
| Theratechnologies Inc. | $4,266 | 7 | $0 (2019) |
| Astellas Pharma US Inc | $99.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,636 | 3 | ViiV Healthcare Company ($6,636) |
| 2023 | $7,824 | 10 | ViiV Healthcare Company ($7,824) |
| 2022 | $1,220 | 1 | Gilead Sciences, Inc. ($1,220) |
| 2021 | $7,845 | 4 | Gilead Sciences, Inc. ($3,500) |
| 2020 | $468.75 | 1 | Merck Sharp & Dohme Corporation ($468.75) |
| 2019 | $26,912 | 42 | Gilead Sciences, Inc. ($14,677) |
| 2018 | $13,977 | 25 | Merck Sharp & Dohme Corporation ($7,284) |
| 2017 | $5,674 | 9 | Gilead Sciences Inc ($5,575) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/22/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| 01/04/2024 | ViiV Healthcare Company | — | Travel and Lodging | Cash or cash equivalent | $115.72 | General |
| 01/04/2024 | ViiV Healthcare Company | — | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| 12/08/2023 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $87.44 | General |
| 12/08/2023 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $71.87 | General |
| 12/08/2023 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $69.48 | General |
| 12/08/2023 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $57.50 | General |
| 12/08/2023 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $31.15 | General |
| 12/08/2023 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $26.50 | General |
| 12/07/2023 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $231.79 | General |
| 12/07/2023 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $113.86 | General |
| 11/06/2023 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $274.96 | General |
| 06/13/2023 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $6,858.97 | General |
| 09/22/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,220.00 | General |
| 12/14/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Consulting Fee | Cash or cash equivalent | $3,220.00 | General |
| Category: HIV | ||||||
| 10/27/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,710.00 | General |
| 03/03/2021 | Gilead Sciences, Inc. | Biktarvy (Drug) | Consulting Fee | Cash or cash equivalent | $1,790.00 | General |
| Category: HIV | ||||||
| 03/01/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 11/04/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Consulting Fee | Cash or cash equivalent | $468.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/09/2019 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Consulting Fee | Cash or cash equivalent | $6,750.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/09/2019 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/04/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/30/2019 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,960.00 | General |
| 09/18/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $64.58 | General |
| 09/18/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $48.79 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 20 | $4,365 | $1,285 |
| 2022 | 1 | 16 | 28 | $5,955 | $2,157 |
| 2021 | 1 | 11 | 24 | $5,040 | $1,702 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 20 | $4,365 | $1,285 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 28 | $5,955 | $2,157 | 36.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 24 | $5,040 | $1,702 | 33.8% |
About Dr. Allison Agwu, M.D
Dr. Allison Agwu, M.D is a Infectious Disease healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598802027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allison Agwu, M.D has received a total of $70,557 in payments from pharmaceutical and medical device companies, with $6,636 received in 2024. These payments were reported across 95 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($57,323).
As a Medicare-enrolled provider, Agwu has provided services to 42 Medicare beneficiaries, totaling 72 services with total Medicare billing of $5,144. Data is available for 3 years (2021–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Other Specialties Pediatric Infectious Diseases, Internal Medicine
- Location Baltimore, MD
- Active Since 02/01/2007
- Last Updated 10/06/2022
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1598802027
Products in Payments
- DELSTRIGO (Drug) $13,050
- Descovy (Drug) $5,957
- EGRIFTA (Drug) $4,266
- CABENUVA (Biological) $3,220
- Biktarvy (Drug) $1,790
- MK-8591A (Drug) $468.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Baltimore
Dr. Robert Redfield, M.d, M.D
Infectious Disease — Payments: $778,508
Luciana Borio, M.d, M.D
Infectious Disease — Payments: $579,903
Dr. Robert Edelman, M.d, M.D
Infectious Disease — Payments: $287,881
Charles Flexner, M.d, M.D
Infectious Disease — Payments: $176,847
Dr. Kjell Wiberg, Md, MD
Infectious Disease — Payments: $137,156
Sara Cosgrove, M.d, M.D
Infectious Disease — Payments: $91,406